Log In
Print this Print this


Also known as: ribavirin

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionRibavirin nucleoside analog for inhalation
Molecular Target Not available
Mechanism of ActionViral replication inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationRespiratory infection
Indication DetailsTreat infant respiratory infection caused by respiratory syncytial virus (RSV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today